MIAMI, FL, OpenEvidence, a widely-used AI platform by doctors in America, announced that it closed a Series D round of funding of $250 million.
OpenEvidence, the most widely-used AI platform by doctors in America, announced that it closed a Series D round of funding, valuing the company at $12 billion. This makes OpenEvidence the most valuable Healthcare AI company in the world. The round was co-led by Thrive Capital and DST Global.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
